European Society of Gynecological Oncology Statement on Fibroid and Uterine Morcellation

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Michael J HalaskaESGO Council

Abstract

Recently, there has been an intense discussion about the issue of fibroid and uterine morcellation in relation to the risk of unrecognized uterine sarcoma spread. Morcellation can negatively influence the prognosis of patients, and transecting the specimen into pieces prevents the pathologist from performing proper disease staging. Many societies have published their statements regarding this issue. The European Society for Gynecological Oncology has established a working group of clinicians involved in diagnostics and treatment of oncogynecological patients to provide a statement from the oncological point of view. Leiomyosarcomas and undifferentiated endometrial sarcomas have generally dismal prognosis, whereas low-grade endometrial stromal sarcomas and adenosarcomas have variable prognosis based on their stage. A focus on the detection of patients at risk of having a sarcoma should be mandatory before every surgery where morcellation is planned by evaluation of risk factors (African American descent, previous pelvic irradiation, use of tamoxifen, rapid lesion growth particularly in postmenopausal patients) and exclusion of patients with any suspicious ultrasonographic signs. Preoperative endometrial biopsy should be mandator...Continue Reading

References

Jul 20, 2007·Journal of Clinical Ultrasound : JCU·Caterina ExacoustosDomenico Arduini
May 29, 2008·Journal of Cancer Research and Clinical Oncology·Jeong-Yeol ParkJoo-Hyun Nam
Sep 25, 2008·British Journal of Cancer·J K ChanD S Kapp
Jul 4, 2012·Gynecologic Oncology·Edward J TannerMartee L Hensley
Mar 15, 2013·JSLS : Journal of the Society of Laparoendoscopic Surgeons·Kelly N WrightJon I Einarsson
Apr 9, 2013·European Radiology·Isabelle Thomassin-NaggaraMarc Bazot
Oct 4, 2013·The New England Journal of Medicine·Serdar E Bulun
Dec 26, 2013·American Journal of Obstetrics and Gynecology·Kenichiro SatoYasuyoshi Fukushima
Nov 8, 2015·The Lancet Oncology·Frédéric AmantDirk Timmerman
May 14, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Mona HoshBasel Refky

❮ Previous
Next ❯

Citations

Mar 30, 2017·Frontiers in Surgery·Enes TaylanAli Akdemir
Oct 5, 2018·Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine·Ying-Jin WangPei-Li An
Sep 6, 2018·Biology of Reproduction·Aymara Mas, Carlos Simón
Nov 5, 2019·Archives of Gynecology and Obstetrics·Günter KöhlerLars Kaderali
Sep 20, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Virginia BenitoBeatriz Pinar
Jun 10, 2020·Current Oncology Reports·Michael J HalaskaIgnacio Zapardiel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenosarcoma

Adenosarcoma is a rare tumor found in women and is located in the uterus, but can also arise in the cervix and ovaries. Discover the latest research on Adenosarcoma here.

Related Papers

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Michael J HalaskaESGO Council
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology
Geetha PuliyathSwetha Singh
Surgical Oncology Clinics of North America
H G Ball, E A Elkadry
© 2022 Meta ULC. All rights reserved